Skip to main content
Erschienen in: La radiologia medica 2/2017

01.02.2017 | CARDIAC RADIOLOGY

The evaluation of non-ischemic dilated cardiomyopathy with T1 mapping and ECV methods using 3T cardiac MRI

verfasst von: Cemile Ayşe Görmeli, Zeynep Maraş Özdemir, Ayşegül Sağır Kahraman, Jülide Yağmur, Ramazan Özdemir, Cemil Çolak

Erschienen in: La radiologia medica | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to examine the correlation between ventricular function and the extracellular volume fraction (ECV) in patients with non-ischemic dilated cardiomyopathy (NIDCM) using 3.0 T magnetic resonance imaging (MRI). We also hypothesized that native T1 and ECV values would be increased in patients with NIDCM, independent of the left ventricular ejection fraction (LVEF). The findings of our study could lead to further studies of the follow-up protocols.

Materials and methods

In total, 53 consecutive dilated cardiomyopathy patients who had undergone cardiac MRI were functionally evaluated and underwent tissue characterization.

Results

The mean native T1 value was 1235 ± 10 ms, and the mean ECV value was 35.4 ± 2.7% in the myocardia. The LVEF values ranged from 29 to 44%. No significant correlations were observed between functional analysis measurements and native T1 or ECV values.

Conclusions

Our results showed that myocardial fibrosis is unrelated to cardiac functional findings in NIDCM patients. Therefore, we propose that these patients should be evaluated using MRI and tissue characterization techniques, in addition to cardiac functional analysis.
Literatur
1.
Zurück zum Zitat Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, Messere J, Cox GF, Lurie PR, Hsu D, Canter C, Wilkinson JD, Lipshultz SE (2006) Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 296:1867–1876. doi:10.1001/jama.296.15.1867 CrossRefPubMed Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, Messere J, Cox GF, Lurie PR, Hsu D, Canter C, Wilkinson JD, Lipshultz SE (2006) Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 296:1867–1876. doi:10.​1001/​jama.​296.​15.​1867 CrossRefPubMed
3.
Zurück zum Zitat Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93:841–842. doi:10.1161/01.CIR.93.5.841 CrossRefPubMed Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93:841–842. doi:10.​1161/​01.​CIR.​93.​5.​841 CrossRefPubMed
4.
Zurück zum Zitat Meinertz T, Hofmann T, Kasper W, Treese N, Bechtold H, Stienen U, Pop T, Leitner ER, Andresen D, Meyer J (1984) Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 53:902–907. doi:10.1016/0002-9149(84)90522-8 CrossRefPubMed Meinertz T, Hofmann T, Kasper W, Treese N, Bechtold H, Stienen U, Pop T, Leitner ER, Andresen D, Meyer J (1984) Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 53:902–907. doi:10.​1016/​0002-9149(84)90522-8 CrossRefPubMed
5.
Zurück zum Zitat de Leeuw N, Ruiter DJ, Balk AH, de Jonge N, Melchers WJ, Galama JM (2001) Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy. Transpl Int 14:299–306. doi:10.1007/s001470100339 CrossRefPubMed de Leeuw N, Ruiter DJ, Balk AH, de Jonge N, Melchers WJ, Galama JM (2001) Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy. Transpl Int 14:299–306. doi:10.​1007/​s001470100339 CrossRefPubMed
7.
Zurück zum Zitat Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW (2008) ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol 51:e1–62. doi:10.1016/j.jacc.2008.02.032 CrossRefPubMed Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW (2008) ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol 51:e1–62. doi:10.​1016/​j.​jacc.​2008.​02.​032 CrossRefPubMed
8.
Zurück zum Zitat Packer DL, Prutkin JM, Hellkamp AS, Mitchell LB, Bernstein RC, Wood F, Boehmer JP, Carlson MD, Frantz RP, McNulty SE, Rogers JG, Anderson J, Johnson GW, Walsh MN, Poole JE, Mark DB, Lee KL, Bardy GH (2009) Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Circulation 120:2170–2176. doi:10.1161/CIRCULATIONAHA.109.853689 CrossRefPubMedPubMedCentral Packer DL, Prutkin JM, Hellkamp AS, Mitchell LB, Bernstein RC, Wood F, Boehmer JP, Carlson MD, Frantz RP, McNulty SE, Rogers JG, Anderson J, Johnson GW, Walsh MN, Poole JE, Mark DB, Lee KL, Bardy GH (2009) Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Circulation 120:2170–2176. doi:10.​1161/​CIRCULATIONAHA.​109.​853689 CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Gunja-Smith Z, Morales AR, Romanelli R, Woessner JF Jr (1996) Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinases and pyridinoline cross-links. Am J Pathol 148:1639–1648PubMedPubMedCentral Gunja-Smith Z, Morales AR, Romanelli R, Woessner JF Jr (1996) Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinases and pyridinoline cross-links. Am J Pathol 148:1639–1648PubMedPubMedCentral
11.
Zurück zum Zitat Nakayama Y, Shimizu G, Hirota Y, Saito T, Kino M, Kitaura Y, Kawamura K (1987) Functional and histopathologic correlation in patients with dilated cardiomyopathy: an integrated evaluation by multivariate analysis. J Am Coll Cardiol 10:186–192. doi:10.1016/S0735-1097(87)80178-X CrossRefPubMed Nakayama Y, Shimizu G, Hirota Y, Saito T, Kino M, Kitaura Y, Kawamura K (1987) Functional and histopathologic correlation in patients with dilated cardiomyopathy: an integrated evaluation by multivariate analysis. J Am Coll Cardiol 10:186–192. doi:10.​1016/​S0735-1097(87)80178-X CrossRefPubMed
12.
Zurück zum Zitat Díez J, Querejeta R, López B, González A, Larman M, Martínez Ubago JL (2012) Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 105:2512–2517. doi:10.1161/01.CIR.0000017264.66561.3D CrossRef Díez J, Querejeta R, López B, González A, Larman M, Martínez Ubago JL (2012) Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 105:2512–2517. doi:10.​1161/​01.​CIR.​0000017264.​66561.​3D CrossRef
13.
Zurück zum Zitat Izawa H, Murohara T, Nagata K, Isobe S, Asano H, Amano T, Ichihara S, Kato T, Ohshima S, Murase Y, Iino S, Obata K, Noda A, Okumura K, Yokota M (2005) Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study. Circulation 112:2940–2945. doi:10.1161/CIRCULATIONAHA.105.571653 PubMed Izawa H, Murohara T, Nagata K, Isobe S, Asano H, Amano T, Ichihara S, Kato T, Ohshima S, Murase Y, Iino S, Obata K, Noda A, Okumura K, Yokota M (2005) Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study. Circulation 112:2940–2945. doi:10.​1161/​CIRCULATIONAHA.​105.​571653 PubMed
14.
Zurück zum Zitat Tamarappoo BK, John BT, Reinier K, Teodorescu C, Uy-Evanado A, Gunson K, Jui J, Chugh SS (2012) Vulnerable myocardial interstitium in patients with isolated left ventricular hypertrophy and sudden cardiac death: a postmortem histological evaluation. J Am Heart Assoc 1:e001511. doi:10.1161/JAHA.112.001511 CrossRefPubMedPubMedCentral Tamarappoo BK, John BT, Reinier K, Teodorescu C, Uy-Evanado A, Gunson K, Jui J, Chugh SS (2012) Vulnerable myocardial interstitium in patients with isolated left ventricular hypertrophy and sudden cardiac death: a postmortem histological evaluation. J Am Heart Assoc 1:e001511. doi:10.​1161/​JAHA.​112.​001511 CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Schelbert EB, Piehler KM, Zareba KM, Moon JC, Ugander M, Messroghli DR, Valeti US, Chang CC, Shroff SG, Diez J, Miller CA, Schmitt M, Kellman P, Butler J, Gheorghiade M, Wong TC (2015) Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the spectrum of ejection fraction and heart failure stage. J Am Heart Assoc 4:e002613. doi:10.1161/JAHA.115.002613 CrossRefPubMedPubMedCentral Schelbert EB, Piehler KM, Zareba KM, Moon JC, Ugander M, Messroghli DR, Valeti US, Chang CC, Shroff SG, Diez J, Miller CA, Schmitt M, Kellman P, Butler J, Gheorghiade M, Wong TC (2015) Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the spectrum of ejection fraction and heart failure stage. J Am Heart Assoc 4:e002613. doi:10.​1161/​JAHA.​115.​002613 CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Dass S, Suttie JJ, Piechnik SK, Ferreira VM, Holloway CJ, Banerjee R, Mahmod M, Cochlin L, Karamitsos TD, Robson MD, Watkins H, Neubauer S (2012) Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy. Circ Cardiovasc Imaging 5:726–733. doi:10.1161/CIRCIMAGING.112.976738 CrossRefPubMed Dass S, Suttie JJ, Piechnik SK, Ferreira VM, Holloway CJ, Banerjee R, Mahmod M, Cochlin L, Karamitsos TD, Robson MD, Watkins H, Neubauer S (2012) Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy. Circ Cardiovasc Imaging 5:726–733. doi:10.​1161/​CIRCIMAGING.​112.​976738 CrossRefPubMed
18.
Zurück zum Zitat Leong DP, Chakrabarty A, Shipp N, Molaee P, Madsen PL, Joerg L, Sullivan T, Worthley SG, De Pasquale CG, Sanders P, Selvanayagam JB (2012) Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography. Eur Heart J 33:640–648. doi:10.1093/eurheartj/ehr391 CrossRefPubMed Leong DP, Chakrabarty A, Shipp N, Molaee P, Madsen PL, Joerg L, Sullivan T, Worthley SG, De Pasquale CG, Sanders P, Selvanayagam JB (2012) Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography. Eur Heart J 33:640–648. doi:10.​1093/​eurheartj/​ehr391 CrossRefPubMed
19.
Zurück zum Zitat Giesbrandt KJ, Bolan CW, Shapiro BP, Edwards WD, Mergo PJ (2013) Diffuse diseases of the myocardium: MRI-pathologic review of cardiomyopathies with dilatation. AJR Am J Roentgenol 200:W274–W282. doi:10.2214/AJR.12.9634 CrossRefPubMed Giesbrandt KJ, Bolan CW, Shapiro BP, Edwards WD, Mergo PJ (2013) Diffuse diseases of the myocardium: MRI-pathologic review of cardiomyopathies with dilatation. AJR Am J Roentgenol 200:W274–W282. doi:10.​2214/​AJR.​12.​9634 CrossRefPubMed
20.
Zurück zum Zitat Holmström M, Kivistö S, Heliö T, Jurkko R, Kaartinen M, Antila M, Reissell E, Kuusisto J, Kärkkäinen S, Peuhkurinen K, Koikkalainen J, Lötjönen J, Lauerma K (2011) Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy. J Cardiovasc Magn Reson 13:30. doi:10.1186/1532-429X-13-30 CrossRefPubMedPubMedCentral Holmström M, Kivistö S, Heliö T, Jurkko R, Kaartinen M, Antila M, Reissell E, Kuusisto J, Kärkkäinen S, Peuhkurinen K, Koikkalainen J, Lötjönen J, Lauerma K (2011) Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy. J Cardiovasc Magn Reson 13:30. doi:10.​1186/​1532-429X-13-30 CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Masci PG, Andreini D, Francone M, Bertella E, De Luca L, Coceani M, Mushtaq S, Mariani M, Carbone I, Pontone G, Agati L, Bogaert J, Lombardi M (2013) Prodromal angina is associated with myocardial salvage in acute ST-segment elevation myocardial infarction. Eur Heart J Cardiovasc Imaging 14:1041–1048. doi:10.1093/ehjci/jet063 CrossRefPubMed Masci PG, Andreini D, Francone M, Bertella E, De Luca L, Coceani M, Mushtaq S, Mariani M, Carbone I, Pontone G, Agati L, Bogaert J, Lombardi M (2013) Prodromal angina is associated with myocardial salvage in acute ST-segment elevation myocardial infarction. Eur Heart J Cardiovasc Imaging 14:1041–1048. doi:10.​1093/​ehjci/​jet063 CrossRefPubMed
24.
Zurück zum Zitat Pastor A, Voigt T, Schaeffter T, Nagel E, Puntmann VO (2012) Usefulness of cardiac magnetic resonance in early assessment of cardiomyopathies: myocardial fibrosis is a common denominator. Curr Cardiovasc Imaging Rep 5:77–82. doi:10.1007/s12410-012-9125-9 CrossRef Pastor A, Voigt T, Schaeffter T, Nagel E, Puntmann VO (2012) Usefulness of cardiac magnetic resonance in early assessment of cardiomyopathies: myocardial fibrosis is a common denominator. Curr Cardiovasc Imaging Rep 5:77–82. doi:10.​1007/​s12410-012-9125-9 CrossRef
25.
Zurück zum Zitat McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, Pennell DJ (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108:54–59. doi:10.1161/01.CIR.0000078641.19365.4C CrossRefPubMed McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, Pennell DJ (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108:54–59. doi:10.​1161/​01.​CIR.​0000078641.​19365.​4C CrossRefPubMed
26.
Zurück zum Zitat Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, Gatehouse PD, Arai AE, Friedrich MG, Neubauer S, Schulz-Menger J, Schelbert EB (2013) Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 15:92. doi:10.1186/1532-429X-15-92 CrossRefPubMedPubMedCentral Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, Gatehouse PD, Arai AE, Friedrich MG, Neubauer S, Schulz-Menger J, Schelbert EB (2013) Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 15:92. doi:10.​1186/​1532-429X-15-92 CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Roller FC, Harth S, Schneider C, Krombach GA (2015) T1, T2 mapping and extracellular volume fraction (ECV): application, value and further perspectives in myocardial inflammation and cardiomyopathies. Rofo 187:760–770. doi:10.1055/s-0034-1399546 CrossRefPubMed Roller FC, Harth S, Schneider C, Krombach GA (2015) T1, T2 mapping and extracellular volume fraction (ECV): application, value and further perspectives in myocardial inflammation and cardiomyopathies. Rofo 187:760–770. doi:10.​1055/​s-0034-1399546 CrossRefPubMed
28.
Zurück zum Zitat Görmeli CA, Görmeli G, Yağmur J, Özdemir ZM, Kahraman AS, Çolak C, Özdemir R (2016) Assessment of myocardial changes in athletes with native T1 mapping and cardiac functional evaluation using 3 T MRI. Int J Cardiovas Imaging 32:975–981. doi:10.1007/s10554-016-0866-4 CrossRef Görmeli CA, Görmeli G, Yağmur J, Özdemir ZM, Kahraman AS, Çolak C, Özdemir R (2016) Assessment of myocardial changes in athletes with native T1 mapping and cardiac functional evaluation using 3 T MRI. Int J Cardiovas Imaging 32:975–981. doi:10.​1007/​s10554-016-0866-4 CrossRef
29.
Zurück zum Zitat Arheden H, Saeed M, Higgins CB, Gao DW, Bremerich J, Wyttenbach R, Dae MW, Wendland MF (1999) Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 211:698–708. doi:10.1148/radiology.211.3.r99jn41698 CrossRefPubMed Arheden H, Saeed M, Higgins CB, Gao DW, Bremerich J, Wyttenbach R, Dae MW, Wendland MF (1999) Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 211:698–708. doi:10.​1148/​radiology.​211.​3.​r99jn41698 CrossRefPubMed
30.
Zurück zum Zitat Jerosch-Herold M, Sheridan DC, Kushner JD, Nauman D, Burgess D, Dutton D, Alharethi R, Li D, Hershberger RE (2008) Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 295:H1234–H1242. doi:10.1152/ajpheart.00429.2008 CrossRefPubMedPubMedCentral Jerosch-Herold M, Sheridan DC, Kushner JD, Nauman D, Burgess D, Dutton D, Alharethi R, Li D, Hershberger RE (2008) Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 295:H1234–H1242. doi:10.​1152/​ajpheart.​00429.​2008 CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Yoon YE, Hong YJ, Kim HK, Kim JA, Na JO, Yang DH, Kim YJ, Choi EY, Korean Society of Cardiology and the Korean Society of Radiology (2014) 2014 Korean guidelines for appropriate utilization of cardiovascular magnetic resonance imaging: a joint report of the Korean Society of Cardiology and the Korean Society of Radiology. Korean J Radiol 15:659–688. doi:10.3348/kjr.2014.15.6.659 CrossRefPubMedPubMedCentral Yoon YE, Hong YJ, Kim HK, Kim JA, Na JO, Yang DH, Kim YJ, Choi EY, Korean Society of Cardiology and the Korean Society of Radiology (2014) 2014 Korean guidelines for appropriate utilization of cardiovascular magnetic resonance imaging: a joint report of the Korean Society of Cardiology and the Korean Society of Radiology. Korean J Radiol 15:659–688. doi:10.​3348/​kjr.​2014.​15.​6.​659 CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Hendel RC, Patel MR, Kramer CM, Poon M, Hendel RC, Carr JC, Gerstad NA, Gillam LD, Hodgson JM, Kim RJ, Kramer CM, Lesser JR, Martin ET, Messer JV, Redberg RF, Rubin GD, Rumsfeld JS, Taylor AJ, Weigold WG, Woodard PK, Brindis RG, Hendel RC, Douglas PS, Peterson ED, Wolk MJ, Allen JM, Patel MR; American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group; American College of Radiology; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance; American Society of Nuclear Cardiology; North American Society for Cardiac Imaging; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology (2006) ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol 48:1475–1497 Hendel RC, Patel MR, Kramer CM, Poon M, Hendel RC, Carr JC, Gerstad NA, Gillam LD, Hodgson JM, Kim RJ, Kramer CM, Lesser JR, Martin ET, Messer JV, Redberg RF, Rubin GD, Rumsfeld JS, Taylor AJ, Weigold WG, Woodard PK, Brindis RG, Hendel RC, Douglas PS, Peterson ED, Wolk MJ, Allen JM, Patel MR; American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group; American College of Radiology; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance; American Society of Nuclear Cardiology; North American Society for Cardiac Imaging; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology (2006) ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol 48:1475–1497
34.
Zurück zum Zitat Di Cesare E, Cademartiri F, Carbone I, Carriero A, Centonze M, De Cobelli F, De Rosa R, Di Renzi P, Esposito A, Faletti R, Fattori R, Francone M, Giovagnoni A, La Grutta L, Ligabue G, Lovato L, Marano R, Midiri M, Romagnoli A, Russo V, Sardanelli F, Natale L, Bogaert J, De Roos A (2013) Clinical indications for the use of cardiac MRI. By the SIRM Study Group on Cardiac Imaging. Radiol Med 118:752–798. doi:10.1007/s11547-012-0899-2 CrossRefPubMed Di Cesare E, Cademartiri F, Carbone I, Carriero A, Centonze M, De Cobelli F, De Rosa R, Di Renzi P, Esposito A, Faletti R, Fattori R, Francone M, Giovagnoni A, La Grutta L, Ligabue G, Lovato L, Marano R, Midiri M, Romagnoli A, Russo V, Sardanelli F, Natale L, Bogaert J, De Roos A (2013) Clinical indications for the use of cardiac MRI. By the SIRM Study Group on Cardiac Imaging. Radiol Med 118:752–798. doi:10.​1007/​s11547-012-0899-2 CrossRefPubMed
39.
Zurück zum Zitat Puntmann VO, Voigt T, Chen Z, Mayr M, Karim R, Rhode K, Pastor A, Carr-White G, Razavi R, Schaeffter T, Nagel E (2013) Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging 6:475–484. doi:10.1016/j.jcmg.2012.08.019 CrossRefPubMed Puntmann VO, Voigt T, Chen Z, Mayr M, Karim R, Rhode K, Pastor A, Carr-White G, Razavi R, Schaeffter T, Nagel E (2013) Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging 6:475–484. doi:10.​1016/​j.​jcmg.​2012.​08.​019 CrossRefPubMed
40.
Zurück zum Zitat Mordi I, Carrick D, Bezerra H, Tzemos N (2015) T1 and T2 mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation. Eur Heart J Cardiovasc Imaging 17:797–803. doi:10.1093/ehjci/jev216 CrossRefPubMed Mordi I, Carrick D, Bezerra H, Tzemos N (2015) T1 and T2 mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation. Eur Heart J Cardiovasc Imaging 17:797–803. doi:10.​1093/​ehjci/​jev216 CrossRefPubMed
41.
Zurück zum Zitat Mascherbauer J, Marzluf BA, Tufaro C, Pfaffenberger S, Graf A, Wexberg P, Panzenböck A, Jakowitsch J, Bangert C, Laimer D, Schreiber C, Karakus G, Hülsmann M, Pacher R, Lang IM, Maurer G, Bonderman D (2013) Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction. Circ Cardiovasc Imaging 6:1056–1065. doi:10.1161/CIRCIMAGING.113.000633 CrossRefPubMed Mascherbauer J, Marzluf BA, Tufaro C, Pfaffenberger S, Graf A, Wexberg P, Panzenböck A, Jakowitsch J, Bangert C, Laimer D, Schreiber C, Karakus G, Hülsmann M, Pacher R, Lang IM, Maurer G, Bonderman D (2013) Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction. Circ Cardiovasc Imaging 6:1056–1065. doi:10.​1161/​CIRCIMAGING.​113.​000633 CrossRefPubMed
42.
Zurück zum Zitat Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA, Shakesprere J, Kellman P, Shroff SG, Schwartzman DS, Mulukutla SR, Simon MA, Schelbert EB (2012) Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation 126:1206–1216. doi:10.1161/CIRCULATIONAHA.111.089409 CrossRefPubMedPubMedCentral Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA, Shakesprere J, Kellman P, Shroff SG, Schwartzman DS, Mulukutla SR, Simon MA, Schelbert EB (2012) Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation 126:1206–1216. doi:10.​1161/​CIRCULATIONAHA.​111.​089409 CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat de Meester de Ravenstein C, Bouzin C, Lazam S, Boulif J, Amzulescu M, Melchior J, Pasquet A, Vancraeynest D, Pouleur AC, Vanoverschelde JL, Gerber BL (2015) Histological validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker Imaging (MOLLI) T1 mapping at 3 T. J Cardiovasc Magn Reson 17:48. doi:10.1186/s12968-015-0150-0 CrossRefPubMedPubMedCentral de Meester de Ravenstein C, Bouzin C, Lazam S, Boulif J, Amzulescu M, Melchior J, Pasquet A, Vancraeynest D, Pouleur AC, Vanoverschelde JL, Gerber BL (2015) Histological validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker Imaging (MOLLI) T1 mapping at 3 T. J Cardiovasc Magn Reson 17:48. doi:10.​1186/​s12968-015-0150-0 CrossRefPubMedPubMedCentral
Metadaten
Titel
The evaluation of non-ischemic dilated cardiomyopathy with T1 mapping and ECV methods using 3T cardiac MRI
verfasst von
Cemile Ayşe Görmeli
Zeynep Maraş Özdemir
Ayşegül Sağır Kahraman
Jülide Yağmur
Ramazan Özdemir
Cemil Çolak
Publikationsdatum
01.02.2017
Verlag
Springer Milan
Erschienen in
La radiologia medica / Ausgabe 2/2017
Print ISSN: 0033-8362
Elektronische ISSN: 1826-6983
DOI
https://doi.org/10.1007/s11547-016-0701-y

Weitere Artikel der Ausgabe 2/2017

La radiologia medica 2/2017 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.